Pulmonary Fibrosis After Pegylated Liposomal Doxorubicin in a Patient with Uterine Papillary Serous Carcinoma
Overview
Affiliations
Evaluation of a non-animal toolbox informed by adverse outcome pathways for human inhalation safety.
de Avila R, Muller I, Barlow H, Middleton A, Theiventhran M, Basili D Front Toxicol. 2025; 7:1426132.
PMID: 40061084 PMC: 11885506. DOI: 10.3389/ftox.2025.1426132.
Drug-induced lung disease: a narrative review.
Bridi G, Fonseca E, Kairalla R, Amaral A, Baldi B J Bras Pneumol. 2024; 50(4):e20240110.
PMID: 39356911 PMC: 11449616. DOI: 10.36416/1806-3756/e20240110.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.
Roncolato F, Lindemann K, Willson M, Martyn J, Mileshkin L Cochrane Database Syst Rev. 2019; 10():CD012160.
PMID: 31588998 PMC: 6953296. DOI: 10.1002/14651858.CD012160.pub2.
Doxorubicin-Induced Cardiomyopathy in Children.
Mancilla T, Iskra B, Aune G Compr Physiol. 2019; 9(3):905-931.
PMID: 31187890 PMC: 7000168. DOI: 10.1002/cphy.c180017.
Jiang C, Liu G, Luckhardt T, Antony V, Zhou Y, Carter A Aging Cell. 2017; 16(5):1114-1124.
PMID: 28722352 PMC: 5595683. DOI: 10.1111/acel.12643.